Shared on 07 Nov 25RYM: Stable Forecasts Will Support Current Share Price LevelsNarrative Update on Ryman Healthcare Analyst Price Target Analysts have maintained their price target for Ryman Healthcare at $3.07, with only minor adjustments to underlying assumptions. They cite stable forecasts for revenue growth and profit margins as reasons for the consistent valuation.Read more0 votesShareShared on 24 Oct 25Fair value Increased 2.85%Narrative Update: Ryman Healthcare Analysts have raised their fair value estimate for Ryman Healthcare from $2.98 to $3.07. This change reflects modest upward revisions to forecasts and is supported by slight improvements in the profit margin outlook.Read more0 votesShareShared on 10 Oct 25Fair value Increased 5.58%Analysts have raised their price target for Ryman Healthcare from $2.83 to $2.98, citing modest improvements in the company’s fair value, profit margin, and growth outlook. Valuation Changes Fair Value has risen slightly from NZ$2.83 to NZ$2.98.Read more0 votesShareShared on 01 May 25Fair value Decreased 2.59%Read more0 votesShare